SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-16-014658
Filing Date
2016-03-14
Accepted
2016-03-14 09:01:34
Documents
86
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mstx-10k_20151231.htm 10-K 2418923
2 EX-21.1 mstx-ex211_9.htm EX-21.1 3703
3 EX-23.1 mstx-ex231_7.htm EX-23.1 2462
4 EX-31.1 mstx-ex311_8.htm EX-31.1 16027
5 EX-31.2 mstx-ex312_10.htm EX-31.2 16076
6 EX-32.1 mstx-ex321_11.htm EX-32.1 10562
  Complete submission text file 0001564590-16-014658.txt   8321730

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mstx-20151231.xml EX-101.INS 1665153
8 XBRL TAXONOMY EXTENSION SCHEMA mstx-20151231.xsd EX-101.SCH 64352
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mstx-20151231_cal.xml EX-101.CAL 58475
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mstx-20151231_def.xml EX-101.DEF 192871
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mstx-20151231_lab.xml EX-101.LAB 476924
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mstx-20151231_pre.xml EX-101.PRE 377753
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130 8585520866
Mast Therapeutics, Inc. (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32157 | Film No.: 161502588
SIC: 2834 Pharmaceutical Preparations